S&P 500   4,526.01 (-1.12%)
DOW   34,487.88 (-0.44%)
QQQ   382.95 (-1.79%)
AAPL   162.44 (-0.81%)
MSFT   323.10 (-1.94%)
FB   305.04 (-1.72%)
GOOGL   2,824.20 (-1.23%)
AMZN   3,395.56 (-1.22%)
TSLA   1,023.75 (-5.61%)
NVDA   306.15 (-4.70%)
BABA   112.16 (-8.07%)
NIO   32.75 (-9.53%)
CGC   10.11 (-2.41%)
AMD   143.05 (-5.06%)
GE   93.06 (-2.28%)
MU   82.50 (-0.46%)
T   23.37 (+1.39%)
F   19.41 (-2.32%)
DIS   146.05 (-0.78%)
PFE   53.75 (+1.34%)
AMC   28.22 (-6.80%)
ACB   5.93 (-3.42%)
BA   197.13 (-2.59%)
S&P 500   4,526.01 (-1.12%)
DOW   34,487.88 (-0.44%)
QQQ   382.95 (-1.79%)
AAPL   162.44 (-0.81%)
MSFT   323.10 (-1.94%)
FB   305.04 (-1.72%)
GOOGL   2,824.20 (-1.23%)
AMZN   3,395.56 (-1.22%)
TSLA   1,023.75 (-5.61%)
NVDA   306.15 (-4.70%)
BABA   112.16 (-8.07%)
NIO   32.75 (-9.53%)
CGC   10.11 (-2.41%)
AMD   143.05 (-5.06%)
GE   93.06 (-2.28%)
MU   82.50 (-0.46%)
T   23.37 (+1.39%)
F   19.41 (-2.32%)
DIS   146.05 (-0.78%)
PFE   53.75 (+1.34%)
AMC   28.22 (-6.80%)
ACB   5.93 (-3.42%)
BA   197.13 (-2.59%)
S&P 500   4,526.01 (-1.12%)
DOW   34,487.88 (-0.44%)
QQQ   382.95 (-1.79%)
AAPL   162.44 (-0.81%)
MSFT   323.10 (-1.94%)
FB   305.04 (-1.72%)
GOOGL   2,824.20 (-1.23%)
AMZN   3,395.56 (-1.22%)
TSLA   1,023.75 (-5.61%)
NVDA   306.15 (-4.70%)
BABA   112.16 (-8.07%)
NIO   32.75 (-9.53%)
CGC   10.11 (-2.41%)
AMD   143.05 (-5.06%)
GE   93.06 (-2.28%)
MU   82.50 (-0.46%)
T   23.37 (+1.39%)
F   19.41 (-2.32%)
DIS   146.05 (-0.78%)
PFE   53.75 (+1.34%)
AMC   28.22 (-6.80%)
ACB   5.93 (-3.42%)
BA   197.13 (-2.59%)
S&P 500   4,526.01 (-1.12%)
DOW   34,487.88 (-0.44%)
QQQ   382.95 (-1.79%)
AAPL   162.44 (-0.81%)
MSFT   323.10 (-1.94%)
FB   305.04 (-1.72%)
GOOGL   2,824.20 (-1.23%)
AMZN   3,395.56 (-1.22%)
TSLA   1,023.75 (-5.61%)
NVDA   306.15 (-4.70%)
BABA   112.16 (-8.07%)
NIO   32.75 (-9.53%)
CGC   10.11 (-2.41%)
AMD   143.05 (-5.06%)
GE   93.06 (-2.28%)
MU   82.50 (-0.46%)
T   23.37 (+1.39%)
F   19.41 (-2.32%)
DIS   146.05 (-0.78%)
PFE   53.75 (+1.34%)
AMC   28.22 (-6.80%)
ACB   5.93 (-3.42%)
BA   197.13 (-2.59%)
NASDAQ:MREO

Mereo BioPharma Group SEC Filings & 10K Form

$1.61
-0.06 (-3.59%)
(As of 12/3/2021 11:25 AM ET)
Add
Compare
Today's Range
$1.60
$1.67
50-Day Range
$1.67
$2.59
52-Week Range
$1.57
$4.71
Volume
17,662 shs
Average Volume
1.50 million shs
Market Capitalization
$109.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.63

Mereo BioPharma Group (NASDAQ:MREO) SEC Filings

DateFilerForm TypeView
09/20/2021
7:20 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2021
4:24 PM
Citibank,N.A./ADR (Filed by)
Mereo BioPharma Group (Subject)
Form F-6EF
08/05/2021
3:33 PM
Mereo BioPharma Group (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
06/02/2021
7:24 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2021
3:10 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2021
4:13 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2021
3:53 PM
Mereo BioPharma Group (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/19/2021
3:27 PM
Mereo BioPharma Group (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G
02/16/2021
3:53 PM
BAKER BROS. ADVISORS LP (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G
02/16/2021
3:30 PM
CITADEL ADVISORS LLC (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G/A
02/10/2021
4:23 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2021
3:53 PM
Mereo BioPharma Group (Filer)
Form 424B5
02/09/2021
4:24 PM
Mereo BioPharma Group (Filer)
Form 424B5
02/01/2021
4:06 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2021
6:06 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2020
4:16 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/15/2020
1:22 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/16/2020
6:27 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2020
5:15 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2020
3:40 PM
Mereo BioPharma Group (Filer)
Form 424B5
10/21/2020
11:15 PM
Mereo BioPharma Group (Filer)
Form EFFECT
10/20/2020
6:12 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/19/2020
7:10 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/13/2020
7:00 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2020
3:05 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2020
8:53 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2020
3:25 PM
Mereo BioPharma Group (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/06/2020
3:10 PM
Citibank,N.A./ADR (Filed by)
Mereo BioPharma Group (Subject)
Form F-6EF
09/29/2020
6:08 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/28/2020
3:43 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/28/2020
7:08 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2020
7:48 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2020
6:00 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/25/2020
10:14 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2020
11:21 PM
Mereo BioPharma Group (Filer)
Form EFFECT
07/10/2020
3:30 PM
Mereo BioPharma Group (Subject)
Vivo Capital IX, LLC (Filed by)
Form SC 13G/A
07/10/2020
9:48 AM
BlackRock Inc. (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G/A
07/09/2020
11:16 PM
Mereo BioPharma Group (Filer)
Form EFFECT
07/02/2020
5:19 AM
Aspire Capital Fund, LLC (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G
06/30/2020
3:07 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/15/2020
3:45 PM
Mereo BioPharma Group (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
06/12/2020
4:00 PM
Mereo BioPharma Group (Subject)
Vivo Capital IX, LLC (Filed by)
Form SC 13G
06/12/2020
11:18 AM
Mereo BioPharma Group (Filer)
Form D
Notice of Exempt Offering of Securities 
05/27/2020
6:37 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2020
8:31 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2020
8:09 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2020
11:15 PM
Mereo BioPharma Group (Filer)
Form EFFECT
03/12/2020
4:15 PM
Mereo BioPharma Group (Filer)
Form F-1/A
03/09/2020
3:31 PM
BlackRock Inc. (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G
03/06/2020
4:32 PM
Mereo BioPharma Group (Filer)
Form F-1/A
02/28/2020
8:46 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2020
8:32 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2020
4:17 PM
Mereo BioPharma Group (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/18/2020
4:15 PM
Mereo BioPharma Group (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
02/18/2020
10:43 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2020
8:48 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2020
7:40 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/13/2020
7:26 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/22/2019
8:29 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2019
11:23 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/17/2019
7:06 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2019
3:05 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/24/2019
3:10 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2019
7:21 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2019
8:27 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/08/2019
1:44 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2019
10:10 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2019
5:56 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2019
12:21 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2019
11:09 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2019
9:08 AM
Mereo BioPharma Group (Filer)
Form 20-F/A
05/23/2019
12:59 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2019
5:09 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2019
1:15 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2019
12:53 PM
Mereo BioPharma Group (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/21/2019
7:33 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2019
11:01 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2019
6:12 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2019
6:10 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2019
1:03 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2019
1:02 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2019
3:06 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2019
1:55 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2019
5:45 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2019
5:40 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2019
3:59 PM
Mereo BioPharma Group (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/29/2019
11:09 AM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2019
1:14 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2019
1:24 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2019
8:14 AM
Mereo BioPharma Group (Filer)
Form CERT
04/23/2019
3:14 PM
Mereo BioPharma Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2019
11:15 PM
Mereo BioPharma Group (Filer)
Form EFFECT
03/20/2019
11:15 PM
Mereo BioPharma Group (Filer)
Form EFFECT
03/20/2019
3:58 PM
Mereo BioPharma Group (Filer)
Form 424B3
03/15/2019
4:08 PM
Mereo BioPharma Group (Filer)
Form F-4/A
03/15/2019
7:34 AM
Mereo BioPharma Group (Filed by)
OncoMed Pharmaceuticals Inc (Subject)
Form 425
03/12/2019
8:27 AM
Mereo BioPharma Group (Filed by)
OncoMed Pharmaceuticals Inc (Subject)
Form 425
02/22/2019
7:59 AM
Mereo BioPharma Group (Filed by)
OncoMed Pharmaceuticals Inc (Subject)
Form 425
02/21/2019
11:31 AM
Mereo BioPharma Group (Filer)
Form RW
02/15/2019
5:50 AM
Mereo BioPharma Group (Filed by)
OncoMed Pharmaceuticals Inc (Subject)
Form 425
This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.